PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-09-30

Date Title Company
30-Sep-2021 UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution UPM Biomedicals
30-Sep-2021 Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses Thermo Fisher Scientific
30-Sep-2021 Nanoform receives funding to solve challenges for global health Nanoform
30-Sep-2021 The Swedish Tax Agency has published a notification on the acquisition cost of shares regarding Moberg Pharma´s distribution of shares in OncoZenge AB Moberg Pharma AB
30-Sep-2021 Medidata Celebrates 10th Anniversary of Industry-Leading Cloud-Based Randomization and Trial Supply Management System Medidata
30-Sep-2021 Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology Thermo Fisher Scientific
30-Sep-2021 OXURION Announces Positive Results from Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME) OXURION
30-Sep-2021 Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival Inbiomotion SL
30-Sep-2021 FDA APPROVES ABBOTT'S AMPLATZER™ TALISMAN™ SYSTEM FOR PFO CLOSURE IN PEOPLE AT RISK OF RECURRENT STROKE Abbott
30-Sep-2021 Asceneuron to Provide Update on O-GlcNAcase Pipeline at Upcoming Conferences Asceneuron SA
30-Sep-2021 LEO Pharma and Veeva Systems Partner for Patient-centric Digital Trials LEO Pharma
30-Sep-2021 Laboratoire Arrow inaugurates its new logistics and industrial site in Lyon Laboratoire Arrow
30-Sep-2021 NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer NuCana
30-Sep-2021 EsoBiotec ready to transform cell therapy cancer treatments EsoBiotec
30-Sep-2021 Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria Novartis
30-Sep-2021 ImmunOs Therapeutics Appoints Claudia Berger as SVP Clinical Development ImmunOs Therapeutics
30-Sep-2021 Advent France Biotechnology launches its second fund with a first close at €86M ($102M) Andrew Lloyd Associates
30-Sep-2021 Global Custom Protein Services Market Top Manufacturers, Latest Innovation with Trends and Forecast 2021 to 2026 CDN Newswire
30-Sep-2021 Global Fatty Acid Synthase (FASN) Inhibitors Market Comprehensive Research Study, Industry Size, Production Development and Opportunities 2021 to 2026 CDN Newswire
30-Sep-2021 Global Angiotensin II Receptor Blocker (ARBs) API Market 2021 Product Type, Industry Segmentation and Technological Innovations to 2026 CDN Newswire